A booth on the conference floor. Panels on the wall, posters on the table, a single board that makes a passing physician stop. Part III, Chapter 3 covers exactly this: posters and exhibition panels shown at academic conference venues. The text itself is brief. But brevity does not mean the rules are loose. Folded into that brevity is an assignment — the writer must apply the spirit of the whole creation guide and judge for themselves.

The chapter comes down to two points. First, the panel must be built according to the spirit of whichever creation-guide chapter its content actually belongs to. Second, reference information follows the rules of Part I, Chapter 3 (the Specific-Item Product Information Summary), section 2-(8). And the package insert (DI) must be easy to consult inside the booth. That is all.

01Why "according to the content"

An exhibition panel is a medium with no fixed shape. Some merely display the product name in large type, like a name-only advertisement. Others line up clinical-trial figures and argue the product's features, like a product information summary. Some confine themselves to explaining a disease. Handing down a single self-contained article "for posters and panels" would simply fail to fit. The discipline is decided not by the name of the medium but by what is written on it — that is the meaning of "build it according to the spirit of the applicable chapter."

This is a plain extension of the foreword's spirit. The foreword states that the guide sets out basic matters rather than covering everything, and that areas left unwritten still fall under the Pharmaceuticals and Medical Devices Act, the Fair Advertising Standards, the sales-information-provision activity guideline, and the JPMA Code. The fact that the manual does not spell out "make posters like this" line by line does not mean freedom. The opposite: the writer must work out what their panel effectively amounts to, and shoulder the constraints of the nearest chapter themselves.

Reading the panel's content for what it is

The clue for judgment is what kind of material the display is. If it carries concrete results, features, and data to speak about one's own product, the spirit of the product information summary — especially the specific-item version — applies. Never exceed the approved scope by a single character; if you write efficacy, show safety at equal or greater prominence; show sources and trial design. Every item of Chapter 1's basic considerations, the foundation, comes down onto the panel intact.

Panel contentSpirit to follow
Centered on product name/logo, no efficacy or safety claimsTreated like a name-only advertisement (avoid implying indication or dosage)
Carries clinical results, features, and data about one's own productSpirit of the (specific-item) product information summary (all of Chapter 1 + approved scope, balance, sources)
Mainly explains a diseaseSpirit of disease-explanation materials (avoid steering toward a specific drug; stop at the therapeutic-class name)

02Reference information — the front line against "true but misleading"

For the handling of reference information, this chapter defers entirely to Part I, Chapter 3, section 2-(8) of the specific-item product information summary. Reference information means secondary material such as results within the approved indication, or the pharmacological action that underpins it. The trouble is that such information "is factual, yet depending on placement can look like the core of the approval."

So the specific-item rules require that reference information not be placed on the cover or the pages immediately following it, not exceed one quarter of the printed area excluding the cover and the DI, and carry no supervisor's commentary. Applying this to an exhibition panel means reference information must not sit where a visitor's eye lands first, nor occupy the largest share of the surface.

One and the same piece of data forms a different image depending on the section it sits in and the place it is put. Displayed large in the center as the main basis of approval, it looks like "the reason this works"; tucked in a corner, labeled "reference information" in small type, it reads as a secondary clue. Even without writing anything false, giving a wrong impression through placement breaches the foreword's "duty not to mislead." Isolating reference information is a structural device that closes this trap of presentation.

The quantitative fence of one quarter

The ceiling "reference information up to one quarter of the surface" is a quantitative fence, not a qualitative prohibition. Why bind it by quantity? If information that is not the core of approval fills half the surface, the weighting a visitor takes away is distorted even if every spot is annotated "reference information." Area sends a silent message. The quantitative cap is the brake that keeps that silent message from stepping past the approved scope.

03Making the DI easy to consult inside the booth

The other explicit requirement is to keep the package insert readily consultable inside the booth. This implements the foreword's positioning: product information summaries and the like complement the package insert, and the original authority is the approved content. The panel is not the original. It is only a window onto approved information. So when a visitor wants to check "what exactly are the contraindications, warnings, and dosage," the original must be within immediate reach.

The same requirement recurs for presentation content and lecture-record collections. The medium changes, but the principle does not: the material sits below the package insert and must never cut off the route back to the original. Whether by tablet or by a printed package insert, the right approach is to provide a path that lets the visitor consult it without leaving the booth.

04The restraint the exhibition setting demands

A conference booth is a place where many visitors pass through in a short time. A momentary visual impression carries weight. For that very reason, overemphasis through visual effects, or a layout that pushes safety aside and enlarges efficacy alone, works especially well here — and is especially dangerous. Because the text is short, the writer bears the responsibility of applying Chapter 1's spirit with their own hands: the balance of efficacy and safety, the ban on exaggeration and misleading, scientific grounding with fairness and objectivity.

The related thinking is continuous with the Fair Advertising Standards (guide to the Fair Advertising Standards) and the JPMA Code (guide to the JPMA Code). The thinner the wording in a given area, the more one needs the posture of returning to these higher norms to judge.

In closing

The chapter on conference posters and exhibition panels gives no detailed procedure of its own; instead it entrusts judgment to the writer. What is entrusted is not freedom but responsibility. Work out what the panel's content amounts to, shoulder the constraints of the nearest chapter, isolate reference information exactly as the specific-item summary requires, and secure a route to the package insert inside the booth.

Behind the short text lies the same question that runs through the entire creation guide. Is this accurate? Does it avoid misleading? Is the road back to the original left open? Even a single exhibition board lives by these three questions.